Elicio Therapeutics, Inc. (ELTX) Free cash flow 2020–2025
Elicio Therapeutics, Inc. (ELTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$37.0MFY2025 · since FY2020: -$22.9M → -$37.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.0M | +0.5% |
| FY2024 | -$37.2M | -13.4% |
| FY2023 | -$32.8M | -43.5% |
| FY2022 | -$22.8M | +56.9% |
| FY2021 | -$53.0M | -131.3% |
| FY2020 | -$22.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice